Understanding and Managing Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Advanced Melanoma

The immune checkpoint inhibitors ipilimumab, nivolumab, and pembrolizumab represent a substantial improvement in treating advanced melanoma but are associated with adverse events (AEs) likely related to general immunologic enhancement. To ensure that patients receive optimal benefit from these agent...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Adv Pract Oncol
Главные авторы: Weinstein, Alyona, Gordon, Ruth-Ann, Kasler, Mary Kate, Burke, Matthew, Ranjan, Smita, Hodgetts, Jackie, Reed, Vanessa, Shames, Yelena, Prempeh-Keteku, Nana, Lingard, Karla
Формат: Artigo
Язык:Inglês
Опубликовано: Harborside Press 2017
Предметы:
Review Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5995532/
https://ncbi.nlm.nih.gov/pubmed/29900017
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы